CVE-2006-0442

Public Exploit

Description

Multiple cross-site scripting (XSS) vulnerabilities in usercp.php in MyBulletinBoard (MyBB) 1.02 allow remote attackers to inject arbitrary web script or HTML via the (1) notepad parameter in a notepad action and (2) signature parameter in an editsig action. NOTE: These are different attack vectors, and probably a different vulnerability, than CVE-2006-0218 and CVE-2006-0219.

Category

4.3
CVSS
Severity: Medium
CVSS 2.0 •
EPSS 0.53%
Vendor Advisory kapda.ir Vendor Advisory secunia.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://kapda.ir/advisory-241.html exploit vendor advisory
http://secunia.com/advisories/18603 third party advisory vendor advisory
http://www.securityfocus.com/archive/1/423128/100/0/threaded mailing list
http://securitytracker.com/id?1015535 vdb entry
http://www.vupen.com/english/advisories/2006/0316 vdb entry
http://www.securityfocus.com/bid/16361 vdb entry

Frequently Asked Questions

What is the severity of CVE-2006-0442?
CVE-2006-0442 has been scored as a medium severity vulnerability.
How to fix CVE-2006-0442?
To fix CVE-2006-0442, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2006-0442 being actively exploited in the wild?
It is possible that CVE-2006-0442 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.